Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.708 USD | -0.28% | +0.97% | -75.84% |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Mar. 14 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 4.6M | Sales 2025 * | 1.3M | Capitalization | 29.14M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -60M | EV / Sales 2024 * | -3.25 x |
Net cash position 2024 * | 44.1M | Net cash position 2025 * | 89.5M | EV / Sales 2025 * | -46.4 x |
P/E ratio 2024 * |
-0.6
x | P/E ratio 2025 * |
-0.7
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.37% |
Latest transcript on Spruce Biosciences, Inc.
1 day | -0.28% | ||
1 week | +0.97% | ||
1 month | -9.91% | ||
3 months | -80.66% | ||
6 months | -37.89% | ||
Current year | -75.84% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 22-01-02 | |
Samir Gharib
DFI | Director of Finance/CFO | 41 | 20-04-30 |
Michael Grey
CHM | Chairman | 71 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Spiegelman
BRD | Director/Board Member | 65 | 20-09-08 |
Michael Grey
CHM | Chairman | 71 | 17-03-31 |
Tiba Aynechi
BRD | Director/Board Member | 48 | 16-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.708 | -0.28% | 243,404 |
24-04-29 | 0.71 | +1.43% | 255,561 |
24-04-26 | 0.7 | -0.14% | 211,577 |
24-04-25 | 0.701 | -0.11% | 379,744 |
24-04-24 | 0.7018 | +0.09% | 450,764 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.84% | 29.14M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- SPRB Stock